Literature DB >> 18785080

[Partial splenic artery embolization for the treatment of a patient with hypersplenism due to liver cirrhosis].

V Guralnik1, A Schäffler, J Schölmerich, H J Schlitt, R Müller-Wille, S Feuerbach, F Obermeier.   

Abstract

HISTORY AND CLINICAL
FINDINGS: A 52-year-old man with liver cirrhosis and ascites, hepatorenal syndrome and severe pancytopenia was admitted to hospital for treatment and consideration for future liver transplantation. INVESTIGATIONS: Laboratory tests revealed severe leukocytopenia and thrombocytopenia, which had persisted after otherwise successful treatment of spontaneous bacterial peritonitis and a hepatorenal syndrome. There was no evidence of a toxic cause such as drugs or alcohol nor of an underlying haematologic disease. The most likely diagnosis was hypersplenism. DIAGNOSIS, THERAPY AND CLINICAL COURSE: Because of the high risk of a splenectomy it was decided to perform a partial splenic arterial embolization. Both leukocyte and thrombocyte counts rose after the intervention and continued to stay within normal range. This made it possible to discharge the patient from inpatient treatment until he was admitted again for a subsequently successful liver transplantation.
CONCLUSIONS: Partial splenic artery embolization can be successfully used to treat severe leukocytopenia and thrombocytopenia in patients with liver cirrhosis and hypersplenism.

Entities:  

Mesh:

Year:  2008        PMID: 18785080     DOI: 10.1055/s-0028-1085572

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  [Liquid embolic agents--Onyx as problem solver].

Authors:  W A Wohlgemuth; W Uller; R Müller-Wille
Journal:  Radiologe       Date:  2013-03       Impact factor: 0.635

2.  Repeated partial splenic artery embolization for hypersplenism improves platelet count.

Authors:  Youwen Tan; Jiamin Wang; Li Sun; Yun Ye
Journal:  Open Med (Wars)       Date:  2022-04-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.